HOME >> BIOLOGY >> NEWS
The World Economic Forum announces new class of technology pioneers for 2006: Ossur selected

a critical role in driving the company towards reaching its goals.
  • Status. The company must not currently be a Member of the World Economic Forum. This criterion applies to the parent company thus wholly-owned subsidiaries of large firms are not eligible.
  • Nominees are evaluated by an external review committee comprised of technology experts with respect to the criteria above.

    In 2005, Ossur single-handedly transformed the nature of prosthetics with the launch of Bionic Technology by Ossur, a new technology platform which pushes the boundary of existing functional capabilities. Founded upon an interdiciplinary and precise fusion of electronics, mechanics, and human physiology, this new range of products includes Ossur's new products: the RHEO KNEETM and the POWER KNEETM, and will soon address the orthopedic market, as well. The goals are to remove the physical limitations caused by a patient's disability; remove the morbidity inherent in some conventional designs; and make the technology available to a wider group of patients.

    The uniqueness of the Technology Pioneer network ensures that companies involved in the development of new technologies are engaged in an integrated and interdisciplinary way. The Technology Pioneers community will provide the Foundation and its members with in-depth knowledge of some of the key technology issues facing society.


    '"/>

    Contact: Beverly Millson
    beverly@missingsock.com
    310-399-7599
    Ossur
    4-Dec-2005


    Page: 1 2 3

    Related biology news :

    1. World Wildlife Fund warns against iron dumping experiment near the Galapagos Islands
    2. Worlds first X-ray free electron laser is on course to completion
    3. Worlds leading scientists announce creation of Encyclopedia of Life
    4. Prize winners announced at ISNs World Congress of Nephrology
    5. World first test potential to identify breast cancer patients who will react badly to radiotherapy
    6. Worlds top engineers in San Antonio for system of systems conference
    7. OneWorld Health selects Odyssey Research for phase 4 study in India
    8. MicrobeWorld podcast wins another award
    9. International Astronautical Federation joins project to protect World Heritage sites
    10. Press registration -- World Congress of Nephrology, April 21-25, 2007, Rio de Janeiro, Brazil
    11. Nature Genetics and the International Society of Nephrology come to Danvers on World Kidney Day

    Post Your Comments:
    (Date:10/15/2014)... risk from strains of influenza virus increases with the ... become complacent that the most substantial threats have been ... pandemics arise when a new virus strain – against ... spreads in the human population. There have been five ... of which – the 1918 Spanish Flu – cost ...
    (Date:10/15/2014)... and to an unexpected extent. The outbreak does not ... virus shows a new disease dynamic in regions, where ... the German National Academy of Sciences Leopoldina, acatech – ... Union of the German Academies of Sciences and Humanities ... , In the statement the academies call for the ...
    (Date:10/15/2014)... Geneticist Fred Alt will be awarded the 44th Rosenstiel ... University for his pioneering research exploring the mechanisms of ... and cancer cells. Alt is the second alumnus to ... the Nobel Prize in 2003. , Alt is the ... Genetics at Harvard Medical School and an investigator at ...
    Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
    (Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis plc ... pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced ... acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., which ... the treatment of diabetic gastroparesis and other GI functional ... Phase 2 trial of relamorelin for the treatment of ...
    (Date:10/22/2014)... WriteResult, LLC – a premier provider ... with a team of researchers from Yale University’s School ... Collaborative to provide electronic questionnaire data collection through use ... started in May, aims to evaluate the impact of ... to and participation in urban agriculture to impact their ...
    (Date:10/22/2014)... Md. , Oct. 22, 2014   Synthetic ... developing novel pathogen-specific therapies for serious infections and diseases, ... has issued a Notice of Allowance for a composition ... its C. difficile program, SYN-004. This is ... SYN-004 in the U.S. and adds to the Company,s ...
    (Date:10/20/2014)... The report “Pharmacy Automation Systems Market by product ... Table-top Counters) by End-user (Inpatient Pharmacy Automation, Outpatient ... 2019” analyzes and studies the major market drivers, ... and the Rest of the World (RoW). , ... through 300 pages and in-depth TOC on "Pharmacy ...
    Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
    Cached News: